泻白散通过抑制ERK/Stat3通路磷酸化及调节多代谢改善急性肺损伤
该研究采用整合药理学方法,在LPS诱导的急性肺损伤(ALI)小鼠中探究泻白散(XBS)的作用机制。结果显示XBS可减轻肺部炎症,主要通过抑制ERK和Stat3磷酸化,并调节花生四烯酸、甘油磷脂和色氨酸代谢途径。
要点
- 泻白散减轻ALI小鼠肺部炎症,减少中性粒细胞浸润及TNF-α、IL-6、IL-1β表达。
- 泻白散抗ALI机制与抑制ERK/Stat3通路磷酸化相关。
- 泻白散调节花生四烯酸、甘油磷脂和色氨酸代谢途径。
核心结论
- 泻白散通过抑制ERK/Stat3通路磷酸化及调节花生四烯酸、甘油磷脂和色氨酸代谢减轻ALI炎症。
研究设计与样本
- 采用UHPLC-QTOF-MS鉴定泻白散化学成分,网络药理学预测靶点,并在LPS诱导的ALI小鼠中评估药效。
- 整合代谢组学和转录组学筛选治疗靶点,并在肺组织中验证。
主要发现
- 在泻白散中鉴定出163种化学成分,构建了「3味药-18成分-86靶点」网络。
- ALI小鼠中,泻白散降低BALF、血清和肺组织中中性粒细胞渗透及TNF-α、IL-6、IL-1β表达。
- 转录组分析提示MAPK、JAK-STAT等通路重要性,与网络药理学预测一致。
- Western blotting和免疫组化显示泻白散主要通过抑制ERK和Stat3磷酸化抗ALI。
- 代谢组揭示泻白散主要调节花生四烯酸、甘油磷脂和色氨酸代谢途径,并验证了白三烯、磷脂酰胆碱、犬尿氨酸等表达水平。
临床怎么用
- 泻白散可能作为ALI的潜在治疗选择,尤其适用于儿童肺炎相关呼吸道疾病。
- 其抗炎作用与抑制ERK/Stat3通路及调节多代谢途径相关,可为临床精准用药提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute lung injury (ALI) often leads to serious respiratory diseases with high incidence rates and mortality. For centuries, Xiebai San (XBS) has been a classical traditional Chinese medicine (TCM) about respiratory illness such as pneumonia in children. However, the related mechanism of XBS against ALI remains indistinct. PURPOSE: To reveal specific targets of XBS in lipopolysaccharide (LPS)-induced ALI mice using integrated pharmacology. STUDY DESIGN: The integrated method was to expound mechanism and targets of XBS inhibited ALI. METHODS: The primary components in XBS were identified by ultra high performance liquid chromatography-quadrupole time of flight-mass spectrometry (UHPLC-QTOF-MS). The potential drug targets were established using network pharmacology. The anti-ALI effect of XBS was evaluated in mice. Additionally, therapeutic targets were screened by integrating metabolome and transcriptome and verified in lung tissue. RESULTS: In total, 163 chemical components were identified in XBS, and a network of "3 drugs-18 components-86 targets" for XBS against ALI was constructed. In ALI mice, XBS alleviated lung inflammation by decreasing permeation and expression of neutrophils, tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) in bronchoalveolar lavage fluid (BALF), serum, and lung tissue. Next, the transcriptome of lung tissue was analyzed and enriched, indicating the importance of mitogen-activated protein kinase (MAPK), Janus kinase-signal transducer and activator of transcription (JAK-STAT), and others, which was consistent with network pharmacology prediction. Also, western blotting and immunohistochemistry results showed that XBS was against ALI mainly by inhibiting extracellular signal regulated kinase (ERK) and signal transducer and activator of transcription 3 (Stat3) phosphorylation. In addition, the metabolome of lung tissue revealed that XBS mainly regulated pathways involved in arachidonic acid, glycerophospholipid, and tryptophan metabolisms. The expression levels of leukotriene, phosphatidylcholine, kynurenine, and others were also verified. CONCLUSION: XBS alleviated inflammation of ALI by inhibiting the phosphorylation of the ERK/Stat3 pathway and regulating arachidonic acid, glycerophospholipid, and tryptophan metabolisms. This study will guide clinical precision medicine and promote modernization of XBS.
引用
- Zhao A, Guo C, Wang L, et al. Xiebai San alleviates acute lung injury by inhibiting the phosphorylation of the ERK/Stat3 pathway and regulating multiple metabolisms. Phytomedicine. 2024. PMID: 38547623. doi:10.1016/j.phymed.2024.155397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。